XM does not provide services to residents of the United States of America.
A
A

AMETEK

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Atlassian, Crowdstrike Holdings, CS Disco

U.S. RESEARCH ROUNDUP-Atlassian, Crowdstrike Holdings, CS Disco July 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Atlassian, Crowdstrike Holdings and CS Disco, on Tuesday. HIGHLIGHTS * Atlassian Corp TEAM.O : Piper Sandler raises to overweight from neutral * Crowdstrike Holdings Inc CRWD.O : Piper Sandler cuts to neutral from overweight * CS Disco Inc LAW.N : JP Morgan cuts to underweight from neutral * Principa
C
C
C
N
P
W
A
C
A
F
L
P
U

U.S. STOCKS Brady Corp, Moderna, crypto shares

BUZZ-U.S. STOCKS ON THE MOVE-Brady Corp, Moderna, crypto shares Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes struggled for direction on Wednesday as investors kept to the sidelines ahead of AI chip leader Nvidia's quarterly results and minutes of the Federal Reserve's policy meeting, due later in the day.
C
T
U
A
U
U
G
A

U.S. STOCKS Dorian, ChargePoint Holdings, Transcat

BUZZ-U.S. STOCKS ON THE MOVE-Dorian, ChargePoint Holdings, Transcat Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes struggled for direction on Wednesday as investors kept to the sidelines ahead of AI chip leader Nvidia's quarterly results and minutes of the Federal Reserve's policy meeting, due later in the day.
C
N
T
U
A
U
U
G
A

Ametek rises after Oppenheimer upgrades to 'outperform'

BUZZ-Ametek rises after Oppenheimer upgrades to 'outperform' ** Industrial technology solutions provider Ametek's shares AME.N rise 1.1% to $171.02, in early trading hours ** Oppenheimer upgrades AME to "outperform" from "perform" ** Price target of $200 represents an 18% upside to the stock's last close ** Says upgrade reflects strong runway to Pa
A

U.S. Ameriprise Financial, Dell Technologies, Stryker

U.S. RESEARCH ROUNDUP-Ameriprise Financial, Dell Technologies, Stryker May 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ameriprise Financial, Dell Technologies and Stryker, on Wednesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : Jefferies raises target price to $500 from $487 * Bio-Techne Corp TECH.O : Citigroup cuts to neutral from buy * Dell Technologies Inc DELL.N : Raymond James raises target price to $
A
A
C
C
U
D
G
A
A
D
I
K
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.